# Staska Pharmaceuticals, Inc. – FDA Inspection, Feb 20, 2026

Source: https://www.keypedia.com/records/fda_inspections/staska-pharmaceuticals-inc/98351a0f-62de-4229-a79d-6603afa06f3c
Source feed: FDA_Inspections

> FDA inspection 1304594 of Staska Pharmaceuticals, Inc., February 20, 2026. 3 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1304594
- Company Name: Staska Pharmaceuticals, Inc.
- Inspection Date: 2026-02-20
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Kansas City District Office
- Citation Count: 3

## Related Documents

- [FDA Inspection 1251377 - 2024-09-18](https://www.keypedia.com/records/fda_inspections/staska-pharmaceuticals-inc/dffc723d-c5d3-4bea-8a2b-9eecceabc624)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/carl-a-huffman/4fa9a65e-2aa5-417c-8369-61edab77c57f)
- [Company Rep](https://www.keypedia.com/people/chad-w-rice/b00f381a-744d-4e5e-90bf-07f60f494afc)

Company: https://www.keypedia.com/companies/staska-pharmaceuticals-inc/1f0a154e-2760-411a-9de6-78da1634f8fc

Office: https://www.keypedia.com/offices/kansas-city-district-office/cd397ab1-df4e-46f1-ab1c-0f6db9abcf79
